Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation

导出

摘要 Objective To study TP53-abnormal MDS/acute myeloid leukemia(AML)patients’allogeneic hematopoietic stem cell transplantation(allo-HSCT)treatment effectiveness and influencing factors.Methods 42patients with TP53 gene status change MDS/AML who underwent allo-HSCT from 2014.8.1 to 2021.7.31 at the Hematology Hospital of the Chinese Academy of Medical Sciences were the subjects of the retrospective analysis.

作者冯丹 FENG Dan(State Experiment Hematol Key Lab,Natl Clin Blood Dis Res Center,Haihe Cell Ecosys Lab,Instit Hematol&Blood Dis Hosp,CAMS&PUMC,Tianjin 300020)

机构地区 State Experiment Hematol Key Lab

出处《China Medical Abstracts(Internal Medicine)》 2023年第3期189-189,共1页 中国医学文摘（内科学分册（英文版）

关键词 TP53 MDS AML

分类号 R457.7 [医药卫生—治疗学]

引文网络
相关文献

1李芳.Clinical study of induction chemotherapy followed by allogeneic hematopoietic stem cell transplantation in the treatment of FLT3-ITD^(+)acute myeloid leukemia with normal karyotype[J].China Medical Abstracts(Internal Medicine),2023,40(3):188-189.
2Ruoyang Shao,Yu Zhang,Jinping He,Fen Huang,Zhiping Fan,Kaibo Yang,Yajing Xu,Na Xu,Yi Luo,Lan Deng,Xi Zhang,Jia Chen,Mingzhe Han,Xudong Li,Sijian Yu,Hui Liu,Xinquan Liang,Xiaodan Luo,Pengcheng Shi,Zhixiang Wang,Ling Jiang,Xuan Zhou,Ren Lin,Yan Chen,Sanfang Tu,Jing Sun,Yu Wang,Qifa Liu,Li Xuan.Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study[J].Signal Transduction and Targeted Therapy,2023,8(10):4903-4913. 被引量：1
3李园.Metagenomic next-generation sequencing of plasma for the identification of bloodstream infectious pathogens in severe aplastic anemia[J].China Medical Abstracts(Internal Medicine),2023,40(3):188-188.
4严欣.Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase[J].China Medical Abstracts(Internal Medicine),2023,40(3):187-188.
5Xiangyu Zhao,Haotian Wu,Yifei Cheng,Zhengli Xu,Yuhong Chen,Yingjun Chang,Yu Wang,Xiaohui Zhang,Lanping Xu,Xiaojun Huang.Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia[J].Chinese Medical Journal,2023,136(16):2011-2013. 被引量：1
6张珏.The impact of low T3 syndrome on the prognosis of patients with newly diagnosed multiple myeloma[J].China Medical Abstracts(Internal Medicine),2023,40(3):189-190.
7《中华转移性肿瘤杂志》编辑部.更正[J].中华转移性肿瘤杂志,2023,6(3):268-268.
8Lingfeng Lu.Enhancing Infection Control:A Comprehensive Analysis of Microbial Testing and Clinical Accuracy Assessment[J].Proceedings of Anticancer Research,2023,7(6):90-95.
9Azeezat Ariwoola,Ehab A. M. Elagab,Tahira Fardous,Saburi Oyewale,Sara Parisi,Heather Williams,Amal M. Shediwah,Islam A. Mahmoud,Ratesh Khillan.Bortezomib-Induced Bilateral Eye Swelling and Cutaneous Adverse Reaction in a Patient with Plasma Cell Leukemia—A Case Report[J].Case Reports in Clinical Medicine,2023,12(11):452-456.
10Jing Liu,Depei Wu,Qifa Liu,Yingjun Chang,Yang Xu,Fen Huang,Xiaojun Huang,Yu Wang.More than two courses of pre-transplant consolidation therapy benefits patients with acute myeloid leukemia in the first complete remission who underwent human leukocyte antigen-matched sibling allografts:a multicenter study[J].Chinese Medical Journal,2023,136(15):1855-1863. 被引量：1

China Medical Abstracts(Internal Medicine)

2023年第3期

浏览历史

内容加载中请稍等...

Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation

相关作者

相关机构

相关主题

浏览历史